NRSN Stock Earnings: NeuroSense Therapeutics Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
NRSN stock results show that NeuroSense Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
The post NRSN Stock Earnings: NeuroSense Therapeutics Beats EPS for Q4 2023 appeared first on InvestorPlace.
More From InvestorPlace